Coronary Stent Market Research Report – Forecast to 2027

Coronary Stent Market Research Report: By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bio Absorbable Stents), by Mode of Delivery (Balloon-Expandable Stents and Self-Expanding Stents), by End-User (Hospitals & Clinics) -Forecast Till 2027

ID: MRFR/MED/4459-HCR | | Region: Global | 100 pages

Coronary Stent Market Overview


The worldwide Coronary Stent Market Size is estimated to rise to have a CAGR of 7.8% during the forecasted time frame of 2023.


You must know that Coronary stents are little stretchy cylinder-like gadgets used to grow the conduits of the patient to forestall blockage. A coronary stent is embedded into the supply route of a patient experiencing a coronary illness because of plaque development. It is utilized for enlarging the narrow corridors and helps diminish chest torment and the possibility of coronary failure. Due to the effective use and high demand for Coronary stents, the Market is expected to enhance its growth in the future period. 


The worldwide Coronary Stent Market Share is fundamentally determined by the high commonness of heart-related sicknesses and tremendous interest in finding and therapy strategies. Furthermore, the expanding accessibility of symptomatic administrations for coronary heart sicknesses likewise energizes the development of the Market. Besides, positive repayment strategies will probably help the Market development in the estimated period. 


In the Coronary Stent Market, you may find various stents for various clinical conditions accessible on the lookout. A stent embed is most regularly utilized for the treatment of heart anomalies, for example hindered veins. Also, stents are embedded in the throat to permit the section of food and refreshments in patients experiencing an oesophageal disease. They are additionally embedded in the ureter to forestall impediment of pee stream from kidney, in the nerve bladder to permit section of bile in patients experiencing nerve bladder disease, and in the mid-region and gastrointestinal lot. Stents are, for the most part, made of metals, polymers, and regular bioabsorbable materials. 


Numerous private and government protection associations are available in evolved nations. More than fifty private insurance agencies are available in the U.S. The arrangements cover over seventy-five percent of the expense of the gadgets and treatment. For example, under the Medicare plan, on the off chance that the normal expense of three stents is around USD 10,000, USD 7,500 is repaid. Moreover, in created nations like the U.K., Canada, and Germany, other comparative repayment approaches are accessible. Then again, elective treatment strategies for coronary supply routes illness and various item reviews might hamper the Coronary Stent Market development. 


COVID 19 Analysis


The outbreak of Covid-19 has affected many industries and markets to a great extent. Among all others, the Coronary Stent Market is most effective due to this pandemic situation. Reducing back of the creation of blood vessel stents is expected, inferable from the spread of the COVID-19 pandemic. Increasing contamination rates have moved the need towards tending to patients with COVID-19. This has consigned non-crisis techniques to the patio, making an accumulation of cardiovascular patients. In any case, heart inconveniences emerging because of the COVID-19 disease, for example, arrhythmia and tachycardia, will be given first concern.


Market Dynamics


Major Drivers of the Market


An increase in the occurrence of CAD and fast reception of coronary stents for the treatment is considered the major driver of the market that is helping develop the Coronary Stent Market to a great extent. Notwithstanding, because of low gross pay in nations like Latin America, there are fewer uses on advancing new techniques and gadgets for the treatment of CAD. The absences of medical care offices and expanded requirements for therapy gadgets for CAD have expanded the infiltration of significant parts in the Middle East district. The Market development is driven by enhancements in the medical services framework and ascends in extra cash.



  • Significant Opportunities For The Market


The major opportunities in the Coronary Stent Market are Bioresorbable Vascular Scaffolds and Emerging Markets. These opportunities play an important role in enhancing the growth of the Market for the estimated period. 


The advancement of a bioresorbable vascular framework (BVS) and extension in developing business sectors give huge development opportunities in the Coronary Stent Market critical development openings on the lookout. Nonetheless, elective treatment strategies for CAD, tough guidelines for item endorsement, and various instances of item disappointment and item review might obstruct the development of this Market during the estimated time frame.



  • Market Restraints


Accessibility of Alternative Treatment Methods for Coronary Artery Disease, Stringent Regulations for Product Approval and Product Failure and Product Recalls is the limiting variable on the lookout in the Coronary Stent Market. 


Elective treatment techniques for CAD and item disappointment and item reviews are a portion of the elements that might impede the general development of the Coronary Stent Market. As coronary stents are grouped under the Class III classification (great danger) of clinical gadgets, the guidelines for their endorsement are incredibly tough. This confines that the quantity of item dispatched in this fragment, influences the Market development.



  • Cumulative Growth Analysis


There has likewise been an appeal for negligibly obtrusive surgeries, which altogether drives the Coronary Stent Market to a great extent. Hence, there has been a decrease in post-employable injury and intricacies with utilizing an insignificantly invasive surgery, which is the significant development driver. Decreased clinic stays and lesser mending-time are different benefits related to the utilization of cutting-edge and scaled-down coronary stents in the Market.


Segment Overview


The worldwide Coronary Stent Market is segmented on type, method of conveyance, material, and end-client. 



  • By Type


Based on type, the Coronary Stent Market is fragmented into uncovered metal stents, drug-eluting stents, and bioabsorbable stents. 



  • By delivery method


The Coronary Stent Market is segmented into swell expandable stents and self-growing stents based on the delivery method. 



  • By Material


Based on material, the Coronary Stent Market is sectioned into metallic stents, cobalt-chromium, platinum chromium, nickel-titanium, tempered steel, and others. 



  • By end-user


The Coronary Stent Market is sectioned into medical clinics and facilities, cardiovascular focuses, careful mobile focuses, and others based on end-client.


Regional Analysis


The American Coronary Stent Market Outlook is divided into two locales, North America and South America. As the biggest market, North America is predominantly determined by the expanding patient populace experiencing coronary illness, developing interest in medical services, and expanding geriatric populace. Besides, the U.S. is the biggest market in North America, attributable to the presence of an enormous number of market players fabricating coronary stents and the expanding mindfulness about hazard factors for coronary illness. Canada is relied upon to be the quickest developing business sector driven by the by and large expanding interest for clinical gadgets with progress in coronary stent gadgets. South America is relied upon to be the quickest developing business sector because of innovative gadgets for finding and the expanding interest for treatment choices of coronary illness.


Competitive Landscape


The major key players of the Coronary Stent Market are mentioned below:-



  • BIOTRONIK SE & Co. KG (Germany)

  • Reva Medical Inc. (U.S.)

  • MicroPort Scientific Corporation (China)

  • B. Braun Melsungen AG (Germany)

  • Transluminal GmbH (Germany)

  • Biosensors International Group, Ltd. (Singapore)

  • Terumo Corporation (Japan)

  • Medtronic plc (Ireland)

  • Boston Scientific Corporation (U.S.)

  • Elixir Medical Corporation (U.S.)

  • Merril Life Sciences Pvt. Ltd. (India)

  • Vascular Concepts (India)

  • Abbott Laboratories (U.S.)

  • STENTS SA (France)

  • Kyoto Medical Planning Co. Ltd. (Japan)


Recent Developments



  • In January 2016, Abbott obtained St. Jude Medical, Inc. (U.S.), a maker of items for cardiovascular breakdown, atrial fibrillation, and heart musicality, the board for USD 25 billion. The securing assisted Abbott with reinforcing its coronary mediation item contributions and increment its essence in the cardiovascular gadgets market. 

  • In May 2016, Boston Scientific teamed up with Mayo Clinic (U.S.) to share licensed innovation and speed the improvement of clinical gadgets. This cooperation centers around the advancement of clinical advances in interventional cardiology, heart musicality the board, endoscopy, neuromodulation, urology, and pelvic wellbeing. This will assist the organization with reinforcing its item contributions.


Report Overview


The Global Coronary Stent Market or overviews are as follows:



  • Global Market Share Overview

  • COVID 19 impact on Global Market

  • Market dynamics

  • Market Value chain analysis 

  • Market Overview

  • Regional Analysis as per the Market Forecast

  • Market Competitive Landscape

  • Market Trends Developments


This report highlights the growth aspects of the global Coronary Stent Market Growth Analysis. Along with that, this report also intends to put up the competitive landscape and recent developments on the table to explain this global Market Analysis.



Report Scope:
Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2018-2023: 7.8%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Mode of delivery, Material, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Medtronic plc (Ireland), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.),STENTYS SA (France), Biosensors International Group, Ltd. (Singapore), Kyoto Medical Planning Co. Ltd. (Japan), Elixir Medical Corporation (U.S.), and Reva Medical Inc. (U.S.)
  Key Market Opportunities   Favorable reimbursement policies
  Key Market Drivers

  • High prevalence of heart-related diseases
  • Huge demand for diagnosis and treatment methods


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Coronary stents are small stretchy tube-like devices used to expand the arteries of the patient in order to prevent blockage. 

    The Coronary Stent Market is expected to exhibit a strong 7.8% CAGR over the forecast period from 2017 to 2023.

    Growing prevalence of heart-related diseases is the major driver for the coronary stent market.

    Americas hold a dominant share in the global market.

    Leading players in the Coronary Stent Market include B. Braun Melsungen, Terumo, and Medtronic, among others.

    Table Of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope Of The Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power Of Suppliers

    5.1.2 Bargaining Power Of Buyers

    5.1.3 Threat Of New Entrants

    5.1.4 Threat Of Substitutes

    5.1.5 Intensity Of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Coronary Stent Market, By Type

    6.1 Introduction

    6.2 Bare-Metal Stents

    6.2.1 Market Estimates & Forecast, 2020–2027

    6.3 Drug-Eluting Stents

    6.3.1 Market Estimates & Forecast, 2020–2027

    6.4 Others

    6.4.1 Market Estimates & Forecast, 2020–2027

    7. Global Coronary Stent Market, By Mode Of Delivery

    7.1 Introduction

    7.2 Balloon-Expandable Stents

    7.2.1 Market Estimates & Forecast, 2020–2027

    7.3 Self-Expanding Stents

    7.3.1 Market Estimates & Forecast, 2020–2027

    8. Global Coronary Stent Market, By Material

    8.1 Introduction

    8.2 Metallic Stents

    8.2.1 Market Estimates & Forecast, 2020–2027

    8.3 Cobalt Chromium

    8.3.1 Market Estimates & Forecast, 2020–2027

    8.4 Platinum Chromium

    8.4.1 Market Estimates & Forecast, 2020–2027

    8.5 Nickel Titaniu

    8.5.1 Market Estimates & Forecast, 2020–2027

    8.6 Stainless Steel

    8.6.1 Market Estimates & Forecast, 2020–2027

    9. Global Coronary Stent Market, By End-User

    9.1 Introduction

    9.2 Hospitals & Clinics

    9.2.1 Market Estimates & Forecast, 2020–2027

    9.3 Cardiac Centers

    9.3.1 Market Estimates & Forecast, 2020–2027

    9.4 Ambulatory Surgical Centers

    9.4.1 Market Estimates & Forecast, 2020–2027

    10. Global Coronary Stent Market, By Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.1 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 U.K.

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest Of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic Of Korea

    10.4.6 Rest Of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest Of The Middle East & Africa

    11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    12 Company Profiles

    12.1 BIOTRONIK SE & Co. KG

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 B. Braun Melsungen AG

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Terumo Corporation

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Medtronic Plc

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 MicroPort Scientific Corporation

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial Overview

    12.5.4 Key Developments

    12.6 Meril Life Sciences Pvt. Ltd

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 Boston Scientific Corporation

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Others

    13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs Of The Market

    13.2 Key Companies To Watch

    13.3 Prediction Of The Coronary Stent Industry

    14 Appendix

    LIST OF TABLES

    Table 1 Coronary Stent Industry Synopsis, 2020–2027

    Table 2 Global Coronary Stent Market Estimates And Forecast, 2020–2027, (USD Million)

    Table 3 Global Coronary Stent Market, By Region, 2020–2027, (USD Million)

    Table 4 Global Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 5 Global Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 6 Global Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 7 North America Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 8 North America Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 9 North America Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 10 U.S. Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 11 U.S. Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 12 U.S. Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 13 Canada Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 14 Canada Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 15 Canada Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 16 South America Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 17 South America Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 18 South America Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 19 Europe Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 20 Europe Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 21 Europe Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 22 Western Europe Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 23 Western Europe Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 24 Western Europe Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 25 Eastern Europe Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 26 Eastern Europe Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 27 Eastern Europe Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 28 Asia Pacific Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 29 Asia Pacific Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 30 Asia Pacific Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    Table 31 Middle East & Africa Coronary Stent Market, By Type, 2020–2027, (USD Million)

    Table 32 Middle East & Africa Coronary Stent Market, By Material, 2020–2027, (USD Million)

    Table 33 Middle East & Africa Coronary Stent Market, By End-User, 2020–2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation For Global Coronary Stent Market

    Figure 3 Segmentation Market Dynamics For Coronary Stent Market

    Figure 4 Global Coronary Stent Market Share, By Type 2020

    Figure 5 Global Coronary Stent Market Share, By Material 2020

    Figure 6 Global Coronary Stent Market Share, By End-User, 2020

    Figure 7 Global Coronary Stent Market Share, By Region, 2020

    Figure 8 North America Coronary Stent Market Share, By Country, 2020

    Figure 9 Europe Coronary Stent Market Share, By Country, 2020

    Figure 10 Asia Pacific Coronary Stent Market Share, By Country, 2020

    Figure 11 Middle East & Africa Coronary Stent Market Share, By Country, 2020

    Figure 12 Global Coronary Stent Market: Company Share Analysis, 2020 (%)

    Figure 13 BIOTRONIK SE & Co. KG: Key Financials

    Figure 14 BIOTRONIK SE & Co. KG: Segmental Revenue

    Figure 16 BIOTRONIK SE & Co. KG: Geographical Revenue

    Figure 17 B. Braun Melsungen AG: Key Financials

    Figure 18 B. Braun Melsungen AG: Segmental Revenue

    Figure 19 B. Braun Melsungen AG: Geographical Revenue

    Figure 20 Terumo Corporation: Key Financials

    Figure 21 Terumo Corporation: Segmental Revenue

    Figure 22 Terumo Corporation: Geographical Revenue

    Figure 23 MicroPort Scientific Corporation: Key Financials

    Figure 24 MicroPort Scientific Corporation: Segmental Revenue

    Figure 25 MicroPort Scientific Corporation: Geographical Revenue

    Figure 26 Medtronic: Segmental Revenue

    Figure 27 Medtronic: Geographical Revenue

    Figure 28 Boston Scientific Corporation. Key Financials

    Figure 29 Boston Scientific Corporation. Segmental Revenue

    Figure 30 Boston Scientific Corporation. Geographical Revenue

    Figure 31 Vascular Concepts. Key Financials

    Figure 32 Vascular Concepts. Segmental Revenue

    Figure 33 Vascular Concepts: Geographical Revenue